FDA Approves Tripling Platelets' Shelf Life Based on UT Health San Antonio Research
April 14, 2020
April 14, 2020
SAN ANTONIO, Texas, April 14 -- The University of Texas Health Science Center at San Antonio issued the following news release:
UT Health San Antonio played a major research role in the FDA's recent approval of a new process that nearly triples the five-day shelf life of blood platelets, commonly used for treating trauma patients.
The breakthrough is expected to increase the availability of platelets, a key blood component that is often in high demand across the state o . . .
UT Health San Antonio played a major research role in the FDA's recent approval of a new process that nearly triples the five-day shelf life of blood platelets, commonly used for treating trauma patients.
The breakthrough is expected to increase the availability of platelets, a key blood component that is often in high demand across the state o . . .